| Not Yet Recruiting | Vitiligo Registry for Adults and Children in the UK NCT06218082 | The Royal Wolverhampton Hospitals NHS Trust | — |
| Not Yet Recruiting | Topical Methotrexate with Fractional CO2 Laser in Treatment of Non Segmental Vitiligo NCT06877455 | Assiut University | N/A |
| Not Yet Recruiting | Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo NCT07152626 | Centre Hospitalier Universitaire de Nice | Phase 2 |
| Not Yet Recruiting | A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo NCT07533019 | Eli Lilly and Company | Phase 2 |
| Not Yet Recruiting | Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo NCT07519031 | Xijing Hospital | Phase 1 / Phase 2 |
| Not Yet Recruiting | Comparative Efficacy of hUCMSC-Secretome Delivered Via Microneedling and Intradermal Microinjection as Adjuvan NCT07509242 | Yohanes Firmansyah, dr, MH, MM | Phase 2 / Phase 3 |
| Not Yet Recruiting | The Value of Adding Mini-oral Pulse Steroid Therapy in Preventing Peri-lesional Halo Post Non-cultured Epiderm NCT07472816 | Cairo University | Phase 4 |
| Recruiting | The Value of Methotrexate in NCES for Stable Vitiligo NCT07352293 | Cairo University | Phase 4 |
| Recruiting | Oral Mini Pulse Dexamethasone in Pediatric Vitiligo NCT07353801 | Cairo University | Phase 4 |
| Not Yet Recruiting | Nevus Removal vs. Conservative Treatment in Halo Nevus With Vitiligo: A Randomized Study NCT07307534 | Xijing Hospital | N/A |
| Not Yet Recruiting | LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in NCT07336641 | Fondazione ISIDE | — |
| Not Yet Recruiting | Building an Assessment Model for Vitiligo Activity and Prognosis Using Peripheral Blood Cytokine Profiles NCT07298551 | Xijing Hospital | — |
| Recruiting | A Real-world Study on the Influencing Factors of Efficacy of Ruxolitinib Cream in Vitiligo NCT07153666 | Peking University Third Hospital | — |
| Recruiting | Betamethasone Phonophoresis For Vitiligo NCT07267273 | Cairo University | N/A |
| Not Yet Recruiting | Vitiligo Severity, Quality of Life, Work Productivity and Activity Impairment NCT06877000 | Assiut University | — |
| Active Not Recruiting | TRPM2 Gene Polymorphism, NLRP3 Inflammasome Expression in Vitiligo Patients NCT07232238 | Aswan University | — |
| Not Yet Recruiting | Immunomodulatory Effects of NB-UVB and Steroids in Vitiligo: A Study on CXCL11 and TEMRA Biomarkers NCT06946069 | Assiut University | N/A |
| Recruiting | Effectiveness of Micro-needling With 5 Fluorouracil Versus Potent Topical Steroids in the Treatment of Limited NCT07398807 | Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan | EARLY_Phase 1 |
| Active Not Recruiting | Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo NCT07532330 | Minia University | N/A |
| Not Yet Recruiting | Microneedling Combined With Topical Crisaborole 2 % Ointment in Treatment of Vitiligo. NCT07088276 | Tanta University | N/A |
| Recruiting | A Proof of Concept, Phase 1 Study of CGB-600 for the Topical Treatment of Non-Segmented Facial Vitiligo NCT07357870 | CAGE Bio Inc. | Phase 1 |
| Withdrawn | Evaluating the Efficacy and Safety of Metformin in Vitiligo NCT05607316 | University of Massachusetts, Worcester | Phase 2 |
| Not Yet Recruiting | The Value of Using Mini-oral Pulse Steroid Therapy Along With Non Cultured Epidermal Cell Suspension (NCES) in NCT06974669 | Cairo University | N/A |
| Completed | Comparative Effectiveness of Ruxolitinib Monotherapy Versus Its Combination With Tacrolimus and Corticosteroid NCT07368673 | Dow University of Health Sciences | Phase 4 |
| Recruiting | Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter NCT06900777 | Xijing Hospital | N/A |
| Recruiting | A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo NCT06905873 | Forte Biosciences, Inc. | Phase 1 |
| Active Not Recruiting | Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo NCT07044141 | Lahore General Hospital | Phase 1 |
| Recruiting | Comparison of Needling and Microneedling Plus Phototherapy in Localized Vitiligo Patients NCT06991972 | Khyber Teaching Hospital | Phase 4 |
| Active Not Recruiting | A Trial of SHR0302Base in Patients With Vitiligo NCT06790862 | Jiangsu HengRui Medicine Co., Ltd. | Phase 2 |
| Completed | A Comparative Study on the Efficacy of Blue Light Emitting Diodes Therapy Versus Targeted Narrow Band UVB in S NCT07174024 | Cairo University | Phase 4 |
| Enrolling By Invitation | Efficacy and Safety of Apremilast in Combination with NBUVB and NBUVB Alone in Vitiligo Patients NCT06593197 | Dow University of Health Sciences | Phase 4 |
| Recruiting | Efficacy of Upadacitinib After NECS in Vitiligo NCT06454461 | Jilin University | N/A |
| Recruiting | Topical Ruxolitinib for Face and Neck Vitiligo of Adult Chinese Patients Refractory to Topical Tacrolimus NCT06719024 | Hospital Authority, Hong Kong | Phase 2 / Phase 3 |
| Active Not Recruiting | A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo NCT06625177 | Teva Branded Pharmaceutical Products R&D LLC | Phase 1 |
| Not Yet Recruiting | Dermoscopy in Nails NCT06696612 | Assiut University | — |
| Recruiting | A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo NCT06602232 | Dren Bio | Phase 1 |
| Completed | Translational Assessment of Vitiligo According to Body Locations NCT06068218 | Centre Hospitalier Universitaire de Nice | N/A |
| Recruiting | Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients. NCT06446063 | Pierre Fabre Dermo Cosmetique | — |
| Recruiting | Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo NCT07187882 | Peking University People's Hospital | N/A |
| Recruiting | Assessment of Hypoxia Inducible Factor and Autophagy Related Genes in Patients With Non-Segmental Vitiligo NCT06410898 | Sohag University | N/A |
| Recruiting | Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions NCT05927272 | University Hospital, Bordeaux | N/A |
| Active Not Recruiting | Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo NCT07181187 | Minghui Pharmaceutical (Hangzhou) Ltd | Phase 2 |
| Unknown | Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients NCT06261073 | Sohag University | N/A |
| Completed | Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin NCT06324695 | Universitätsklinikum Hamburg-Eppendorf | N/A |
| Unknown | Evaluation of Pyroptosis-related Indicators in the Pathogenesis of Vitiligo:Across-sectional Comparative Study NCT06261086 | Sohag University | N/A |
| Unknown | Insulin Like Growth Factor-1 Against Oxidative Stress in Vitiligo NCT05812079 | Cairo University | — |
| Completed | 5-fluorouracil for Treatment of Stable Vitiligo NCT06209138 | Al-Azhar University | N/A |
| Recruiting | A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitili NCT06163326 | Pfizer | Phase 3 |
| Completed | The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia. NCT07046039 | King Abdulaziz University | — |
| Unknown | Tregs CD25 CXCL9 in Vitiligo NCT05569096 | Assiut University | — |
| Active Not Recruiting | A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Partic NCT06118411 | AbbVie | Phase 3 |
| Unknown | A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermat NCT06319781 | Blueskin AS | — |
| Recruiting | Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus P NCT05917561 | University Hospital, Bordeaux | Phase 2 |
| Completed | Vitiligo and Psychodrama Therapy NCT05991596 | Azienda Sanitaria Universitaria Integrata del Trentino | N/A |
| Active Not Recruiting | A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UV NCT06109649 | Clinuvel, Inc. | Phase 3 |
| Completed | In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Al NCT05544448 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | Promoting Repigmentation After Epidermal Cell Suspension Grafting and preVENTing the Loss of Melanocytes Using NCT05872477 | Centre Hospitalier Universitaire de Nice | Phase 2 |
| Completed | Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells NCT05971381 | Avita Medical | N/A |
| Completed | Investigating Healthcare Disparities in Vitiligo NCT06097494 | Momentum Data | — |
| Unknown | Histochemical Study of Vitiligo in Sohag University Hospital Patients NCT05869942 | Sohag University | N/A |
| Unknown | A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological NCT05084417 | OM1, Inc. | — |
| Completed | Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo NCT04237103 | University Hospital, Bordeaux | Phase 2 |
| Active Not Recruiting | Evaluation of Serological Markers of Vitiligo Activity NCT06731283 | Hospital de Clinicas de Porto Alegre | — |
| Recruiting | Platelet-rich Plasma Intradermal Injection Combined With 308 nm Excimer Light for Treating Stable Acral Vitili NCT06394349 | Yijian Zhu | N/A |
| Completed | T Central Memory Cells in Early Localized Non-Segmental Vitiligo NCT05706636 | Cairo University | N/A |
| Active Not Recruiting | Use of Allogeneic Extracellular Secretomes (EV)Derived From Umbilical Cord Mesenchymal Stromal Cells: a Phase NCT06813027 | University of Jordan | Phase 1 |
| Unknown | Role of NGAL in Vitiligo NCT05290077 | Sohag University | N/A |
| Unknown | Assessment of Serum Leptin in Vitiligo Patients NCT05549869 | Sohag University | N/A |
| Recruiting | Topical 5-Fluorouracil Effervescent Powder in the Treatment of Vitiligo NCT05536856 | Al-Azhar University | Phase 4 |
| Unknown | A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the Fac NCT05210582 | Clinuvel, Inc. | Phase 2 |
| Completed | Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating V NCT06035614 | Clarteis | N/A |
| Unknown | How Does Skin Tone Affect Quantitative Photoacoustic Imaging NCT05554523 | University of Cambridge | — |
| Completed | Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo NCT05298033 | University of Colorado, Denver | Phase 2 |
| Unknown | Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental NCT05008887 | Assiut University | Phase 4 |
| Completed | Evaluation of Efficacy of Microneedling and Topical Methotrexate Versus Microneedling and Topical 5-flourourac NCT05467839 | Sohag University | N/A |
| Active Not Recruiting | Daily Topical Rapamycin for Vitiligo NCT05342519 | Medical University of South Carolina | Phase 2 |
| Unknown | Role of Tofacitinib in Vitiligo Patients NCT05293119 | Pi Research Consultancy Center, Bangladesh | EARLY_Phase 1 |
| Completed | A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream With Phototherapy in Participants With Vitili NCT05247489 | Incyte Corporation | Phase 2 |
| Completed | Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo. NCT05513924 | South Valley University | Phase 2 / Phase 3 |
| Unknown | Ocular Changes in Vitiligo Patients on Therapy NCT05335746 | Benha University | — |
| Unknown | Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo NCT05121532 | Sohag University | N/A |
| Unknown | Improved Phototherapy in Patients With Vitiligo NCT05836441 | The First Affiliated Hospital with Nanjing Medical University | N/A |
| Completed | Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment NCT04738149 | Medical University of South Carolina | EARLY_Phase 1 |
| Recruiting | Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Init NCT05635266 | Sanguine Biosciences | — |
| Completed | The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic NCT05098600 | Faculty Hospital Kralovske Vinohrady | — |
| Completed | Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo NCT04971200 | Premier Specialists, Australia | EARLY_Phase 1 |
| Completed | Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo NCT04872257 | Hospital Universitario Dr. Jose E. Gonzalez | N/A |
| Withdrawn | Hair Transplantation for Treatment of Vitiligo NCT04858152 | Mehdi Rashighi | N/A |
| Unknown | Treatment of Acral Vitiligo : Narrowband Ultraviolet-B and Microneedling With and Without Platelet Rich Plasma NCT03155698 | Assiut University | N/A |
| Completed | Tissue-resident Memory T Cells Expression Among the Repigmentation Patterns Induced by NB-UVB Phototherapy in NCT05506995 | Universidad Autonoma de San Luis Potosí | — |
| Completed | A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo NCT05053022 | Crown Laboratories, Inc. | N/A |
| Completed | Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in A NCT04822584 | University Hospital, Bordeaux | Phase 2 |
| Completed | A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA) NCT04896385 | Incyte Corporation | Phase 2 |
| Completed | Mental Health Associations With Vitiligo NCT04953338 | Momentum Data | — |
| Completed | Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo NCT04969419 | Momentum Data | — |
| Completed | ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric I NCT04843059 | Centre Hospitalier Universitaire de Nice | N/A |
| Completed | Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo NCT05577637 | Combined Military Hospital Abbottabad | Phase 1 |
| Unknown | Defining the Role of the Skin Microbiome in Immune-related Adverse Events NCT04734704 | University Hospital, Bordeaux | N/A |
| Unknown | Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up NCT04789993 | Central Hospital, Nancy, France | — |
| Terminated | Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo NCT04811131 | Arcutis Biotherapeutics, Inc. | Phase 2 |
| Unknown | Comparison Between Systemic Steroids, Topical Steroids, or Calcineurin Inhibitors With Mini Punch Grafting in NCT04765826 | Alexandria University | N/A |
| Completed | Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo NCT04775979 | Ain Shams University | Phase 4 |
| Unknown | Enhanced Transcutaneous Delivery of Betamethasone for the Treatment of Vitiligo NCT05233735 | Tel-Aviv Sourasky Medical Center | N/A |
| Unknown | Effect Of Topical Prostaglandin F2α Analogs,Fractional CO2 Laser, Excimer Laser Or Their Combination In Treatm NCT04577027 | Assiut University | Phase 4 |
| Unknown | Resident Memory T Cells in Vitiligo NCT05223738 | Kasr El Aini Hospital | — |
| Completed | Evaluation of AMG 714 for Vitiligo NCT04338581 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Tofacitinib for Immune Skin Conditions in Down Syndrome NCT04246372 | University of Colorado, Denver | Phase 2 |
| Completed | The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata NCT04239521 | Momentum Data | — |
| Terminated | Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation NCT04271501 | Avita Medical | N/A |
| Completed | Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo NCT04530344 | Incyte Corporation | Phase 3 |
| Completed | Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Les NCT04547998 | Avita Medical | N/A |
| Unknown | Evaluation of Human Melanocytes After the Use of PRP Versus Fractional CO2 Laser in Vitiligo NCT04320160 | Assiut University | N/A |
| Unknown | Efficacy of Red Light in the Treatment of Pigmentary Disorders NCT04308421 | University of British Columbia | N/A |
| Completed | Correlation of Glucose and Lipid Metabolism Levels With Vitiligo NCT05968235 | Xijing Hospital | — |
| Terminated | Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo NCT04774809 | Reistone Biopharma Company Limited | Phase 2 / Phase 3 |
| Unknown | Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of NCT04171427 | Laboratoire Dermatologique ACM | N/A |
| Completed | Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo NCT04103060 | Dermavant Sciences GmbH | Phase 2 |
| Unknown | Prevalence of Psoriasis and Vitiligo in Assiut Governorate, Egypt NCT04039451 | Assiut University | — |
| Completed | Effects of Combination Therapy With Camouflage in the Repigmentation of Vitiligo NCT03973073 | Peking University People's Hospital | Phase 1 |
| Completed | Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo. NCT03941808 | Centre Hospitalier Universitaire de Nice | N/A |
| Unknown | Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis an NCT03976622 | University Hospital, Bordeaux | — |
| Unknown | E-cadherin and Integrin Alpha v Beta 1 in Vitiligo NCT05287776 | Kasr El Aini Hospital | N/A |
| Recruiting | The Gut and Skin Microbiome in Vitiligo Disease Progression NCT03577327 | Northwestern University | — |
| Completed | PHNA, Efficacy of Tretinoin Cream on Post-phototherapy Hyperpigmentation NCT03933774 | The Catholic University of Korea | N/A |
| Unknown | Human Beta-defensin 1 in Vitiligo NCT03832751 | Cairo University | N/A |
| Unknown | Punch Minigraft Versus Transverse Needling or Combination of Both in Treatment of Non-Segmental Vitiligo NCT03872804 | Alexandria University | N/A |
| Active Not Recruiting | A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC NCT03661866 | Target PharmaSolutions, Inc. | — |
| Unknown | Prostaglandin F2-alpha (PGF2α) in Vitiligo NCT03755830 | Cairo University | N/A |
| Unknown | Fractional Carbon Dioxide Laser,Topical Corticosteroid and Narrow Band Ultraviolet B in Treatment of Stable Vi NCT03158675 | Assiut University | N/A |
| Unknown | Contribution of Skin Color in Stabilization of Active Cases of Vitiligo by Narrow Band UVB NCT04030988 | Ain Shams University | Phase 1 |
| Unknown | Microneedling and Latanoprost in Acrofacial Vitiligo NCT03611348 | Sohag University | Phase 2 / Phase 3 |
| Completed | The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitili NCT03741738 | Yonsei University | — |
| Completed | Metabolic Syndrome in Early Onset Versus Late Onset Vitiligo NCT03622320 | Cairo University | — |
| Completed | Synergistic Effect of Vitamin D Supplementation in Patients With Vitiligo and Vitamin D Deficiency NCT05364567 | Hallym University Kangnam Sacred Heart Hospital | N/A |
| Completed | Efficacy and Safety of Total Glucosides of Paeony Combined With NB-UVB on Treating Vitiligo NCT03608917 | xjpfW | N/A |
| Completed | A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo NCT03468855 | Aclaris Therapeutics, Inc. | Phase 2 |
| Unknown | Comparative Study of Surgical Treatment of Vitiligo NCT03497208 | Hospital de Clinicas de Porto Alegre | N/A |
| Unknown | Comparing Recipient Site Preparation Using Dermabrasion, Dermaroller and Liquid Nitrogen Induced Blister in No NCT03668834 | Post Graduate Institute of Medical Education and Research, Chandigarh | N/A |
| Unknown | Maintenance Therapy of Narrow-band UV-B Therapy in Patients With Vitiligo NCT03384342 | The Catholic University of Korea | N/A |
| Unknown | Maintenance Therapy of 308-nm Excimer Laser Therapy in Patients With Vitiligo NCT03384459 | The Catholic University of Korea | N/A |
| Unknown | Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo NCT03365141 | The Catholic University of Korea | N/A |
| Unknown | Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases NCT03340155 | Medical University of Graz | N/A |
| Completed | Photoprotection Habits in Patients With Vitiligo NCT03323125 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy NCT03270241 | Johns Hopkins University | N/A |
| Unknown | Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo NCT03358082 | Sohag University | Phase 1 / Phase 2 |
| Terminated | Evaluating the Efficacy of the Melanocyte Keratinocyte Transplantation Procedure in the Treatment of Vitiligo NCT04374435 | University of California, Irvine | N/A |
| Unknown | Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients Wit NCT03199664 | South Valley University | Phase 4 |
| Unknown | Comparison of Surgical Methods on Resistant Sites in Stable Vitiligo Patients NCT03717025 | Post Graduate Institute of Medical Education and Research, Chandigarh | N/A |
| Completed | A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo NCT03099304 | Incyte Corporation | Phase 2 |
| Completed | Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo NCT03123016 | Icahn School of Medicine at Mount Sinai | Phase 2 |
| Completed | Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO NCT03036995 | Centre Hospitalier Universitaire de Nice | Phase 2 |
| Completed | Evaluation of Scanoskin for the Assessment of Vitiligo NCT03133871 | Chelsea and Westminster NHS Foundation Trust | — |
| Completed | Thymic Stromal Lymphopoietin (TSLP) in Vitiligo NCT03367273 | Cairo University | N/A |
| Terminated | ReNovaCell in Non-segmental Vitiligo NCT03022019 | Netherlands Institute for Pigment Disorders | N/A |
| Completed | Secukinumab in Active Non-segmental Vitiligo NCT05676333 | University Hospital, Ghent | Phase 4 |
| Unknown | Efficacy of 311-nm Ti:Sapphire Laser Versus 308-nm Excimer Laser Treatment in Vitiligo NCT02925767 | The Catholic University of Korea | N/A |
| Completed | Study of the Role of Innate Lymphoid Cells and Natural Killer Cells in Immune Activation of Vitiligo - INNATE NCT03859518 | Centre Hospitalier Universitaire de Nice | — |
| Unknown | Long-term Follow-up in Patients Affected With Acrofacial Vitiligo NCT01459055 | Irmandade da Santa Casa de Misericordia de Curitiba | — |
| Completed | Vitiligo Extent Score (VES) Score in Comparison to Vitiligo Area and Severity Index (VASI) Score NCT03411135 | Cairo University | — |
| Unknown | Transplantation of Basal Cell Layer Suspension Using Derma-rolling System in Vitiligo NCT02962180 | Mohammed V Souissi University | N/A |
| Completed | Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC NCT02466997 | University Hospital, Bordeaux | Phase 3 |
| Completed | Topical Ruxolitinib for the Treatment of Vitiligo NCT02809976 | Tufts Medical Center | Phase 2 |
| Unknown | A Novel Surgical Method in the Treatment of Unstable Vitiligo NCT03013049 | Post Graduate Institute of Medical Education and Research, Chandigarh | N/A |
| Completed | Janus Kinase 1 in Vitiligo & Psoriasis NCT03762551 | Cairo University | N/A |
| Completed | Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Pa NCT03249064 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | — |
| Completed | Effect of Early Systemic Stabilization Therapy on Recent Onset Vitiligo NCT05037981 | Cairo University | — |
| Completed | Stress Response Pathways in Vitiligo NCT02797574 | NYU Langone Health | N/A |
| Terminated | Effect of Combination Non Steroidal Antiinflammatory Drugs and Narrowband UVB Treatment in Non-Photoadapters NCT05256147 | Henry Ford Health System | N/A |
| Completed | Comparison of Cyclic On-off and Continuous Excimer Laser Treatment for Vitiligo NCT03047733 | Ajou University School of Medicine | N/A |
| Terminated | Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo NCT02506101 | Johns Hopkins University | N/A |
| Withdrawn | Fractional Laser in Combination With UVB Therapy in Vitiligo Patients NCT02290717 | Netherlands Institute for Pigment Disorders | N/A |
| Completed | Atorvastatin in Active Vitiligo NCT02432534 | Centre Hospitalier Universitaire de Nice | Phase 2 |
| Unknown | Open-label Pilot Study of Abatacept for the Treatment of Vitiligo NCT02281058 | Brigham and Women's Hospital | Phase 1 |
| Terminated | Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo NCT02191748 | Rutgers, The State University of New Jersey | Phase 2 / Phase 3 |
| Completed | To Study the Efficacy of Therapeutic Pulsed Ultrasound in the Treatment of Vitiligo: a Randomized, Intra-indiv NCT03864315 | National Taiwan University Hospital | N/A |
| Completed | Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (N NCT04525157 | Clinuvel Pharmaceuticals Limited | Phase 2 |
| Completed | Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebal NCT02156427 | Laboratoires Genévrier | Phase 3 |
| Terminated | Efficacy of Autologous Outer-Root-Sheath Melanocytes Transplantation in the Treatment of Vitiligo NCT01923142 | Centro Studi Gised | Phase 2 |
| Unknown | Comparative Study Using Dermabrasion vs CO2 Laser & Collagen Dressing vs Vaseline Gauze in MKTP NCT02038257 | Henry Ford Health System | N/A |
| Unknown | Repigmentation Patterns Induced by NB-UVB and Their Relationship With Melanocytic Migration in Vitiligo NCT02625012 | Juan Pablo Castanedo-Cazares | — |
| Completed | Photocil (Topical) for the Treatment of Vitiligo NCT01992185 | Applied Biology, Inc. | N/A |
| Completed | NB-UVB and PUVA Vitiligo Study NCT01732965 | Henry Ford Health System | Phase 4 |
| Unknown | Efficacy of Red Light in Vitiligo NCT01787708 | University of British Columbia | Phase 2 |
| Unknown | Topical Psoralen Ultraviolet Light A Versus Narrow Band Ultraviolet Light B Treatment for Recalcitrant Dermato NCT01792245 | University of British Columbia | Phase 2 |
| Unknown | UVA 1 Phototherapy for Vitiligo NCT01787695 | University of British Columbia | Phase 2 |
| Unknown | Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo NCT01766609 | University of British Columbia | Phase 2 |
| Completed | HI-Light Pilot Trial for Vitiligo: Hand Held NB-UVB for Early or Focal Vitiligo at Home NCT01478945 | University of Nottingham | N/A |
| Withdrawn | Efficacy and Safety of ACH24 in the Treatment of Vitiligo NCT01419964 | Ache Laboratorios Farmaceuticos S.A. | Phase 3 |
| Completed | Clinical Trial of Simvastatin to Treat Generalized Vitiligo NCT01517893 | John Harris | Phase 2 |
| Terminated | Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control NCT01841008 | Centre Hospitalier Universitaire de Nice | Phase 2 / Phase 3 |
| Terminated | A New Micrografting Technique for Vitiligo NCT01262547 | Massachusetts General Hospital | Phase 2 |
| Completed | Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo NCT01382589 | Clinuvel Pharmaceuticals Limited | Phase 2 |
| Completed | Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV) NCT01430195 | Clinuvel Pharmaceuticals Limited | Phase 1 |
| Completed | Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo NCT01511965 | Centre Hospitalier Universitaire de Nice | Phase 1 / Phase 2 |
| Completed | Epidermal Cell Transplantation in Vitiligo Skin NCT01629979 | Centre Hospitalier Universitaire de Nice | Phase 2 / Phase 3 |
| Terminated | Treatment of Vitiligo With Low-energy Visible Light Laser NCT01259986 | Henry Ford Health System | N/A |
| Withdrawn | Topical Bimatoprost Solution 0.03%in Stable Vitiligo NCT01202513 | Gian Sagar Medical College and Hospital | Phase 4 |
| Withdrawn | Comparative Study of Techniques in Melanocyte-Keratinocyte Transplantation for the Treatment of Vitiligo NCT01822379 | Henry Ford Health System | Phase 2 / Phase 3 |
| Completed | Interest of the Dermabrasion by Laser Erbium in the Treatment of the Vitiligo NCT01087216 | Centre Hospitalier Universitaire de Nice | Phase 2 / Phase 3 |
| Completed | Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Ana NCT01082393 | University Hospital, Ghent | Phase 4 |
| Completed | Effect of Procedural Variables on Outcome of Surgical Treatment of Vitiligo NCT02510651 | Cairo University | Phase 1 |
| Unknown | Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo NCT01333410 | Mahidol University | Phase 4 |
| Completed | Botulinum Toxin Treatment for Localized Vitiligo NCT01051687 | King Saud University | Phase 4 |
| Completed | Autologous Transplantation of Melanocytes for Treatment of Vitiligo Skin NCT00631865 | Royan Institute | Phase 3 |
| Completed | Vitiligo Skin Transplantation NCT00830713 | Henry Ford Health System | Phase 3 |
| Unknown | Oral Ginkgo Biloba and Narrow Band UVB in the Treatment of Vitiligo NCT01006421 | King Saud University | — |
| Terminated | In Vivo Imaging of Pigmentary Disorders by Reflectance Confocal Microscopy NCT00771355 | Massachusetts General Hospital | — |
| Completed | Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment NCT00615355 | Medical University of Graz | N/A |
| Completed | The Efficacy of Hand Narrow-Band Ultraviolet B (NBUVB) Versus Excilite Treatment in Vitiligo After Minigraftin NCT00622180 | University of Texas Southwestern Medical Center | N/A |
| Unknown | Virus Early Transcription Factor (VETF) Multicenter Phototherapy Protocol NCT00525395 | Istituti Fisioterapici Ospitalieri | Phase 3 |
| Completed | Narrowband UVB Treatment in Patients With Vitiligo NCT00398723 | Mary Sullivan-Whalen | N/A |
| Unknown | The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis NCT00509314 | National Taiwan University Hospital | — |
| Completed | Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo NCT00367224 | Henry Ford Health System | N/A |
| Unknown | Treatment and Complication of Bath PUVA in Vitiligo NCT00380471 | Shahid Beheshti University of Medical Sciences | Phase 2 |
| Completed | Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo NCT00807690 | Oslo University Hospital | Phase 3 |
| Unknown | Molecular Mechanisms of Helium-Neon Laser on Melanocyte Regeneration in Skin Equivalent Vitiligo Model NCT00172939 | National Taiwan University Hospital | Phase 1 |
| Completed | Optimal Treatment Frequency of 308-Nm Excimer Laser for Vitiligo on the Face and Neck NCT00368407 | Air Force Military Medical University, China | — |
| Terminated | Examination Of Vitiligo Skin Samples Before and After UVB Treatment NCT00177034 | Mimi Cho, MD | N/A |
| Completed | Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo NCT00134368 | University of Medicine and Dentistry of New Jersey | Phase 2 |
| Completed | Psychiatric Problems in Chronic Skin Diseases NCT00167752 | University of Wisconsin, Madison | — |
| Completed | Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity NCT03941184 | Mayo Clinic | — |
| Completed | Excimer Lamp Versus Excimer Laser in Vitiligo Treatment NCT00696358 | Centre Hospitalier Universitaire de Nice | Phase 3 |
| Unknown | Audiological Disturbances in Vitiligo NCT00484224 | Hadassah Medical Organization | — |